Serrano Sponton Lucas, Oehlschlaegel Florian, Nimer Amr, Schwandt Eike, Glaser Martin, Archavlis Eleftherios, Conrad Jens, Kantelhardt Sven, Ayyad Ali
Department of Neurosurgery, Sana Klinikum Offenbach, Offenbach am Main, Germany.
Department of Neurosurgery, Mainz University Medical Centre, Mainz, Germany.
J Neurol Surg B Skull Base. 2022 Jun 29;84(4):349-360. doi: 10.1055/s-0042-1751000. eCollection 2023 Aug.
The endoscopic-assisted supraorbital approach (eSOA) constitutes a minimally invasive strategy for removing anterior skull base meningiomas (ASBM). We present the largest retrospective single-institution and long-term follow-up study of eSOA for ASBM resection, providing further insight regarding indication, surgical considerations, complications, and outcome. We evaluated data of 176 patients operated on ASBM via the eSOA over 22 years. Sixty-five tuberculum sellae (TS), 36 anterior clinoid (AC), 28 olfactory groove (OG), 27 planum sphenoidale, 11 lesser sphenoid wing, seven optic sheath, and two lateral orbitary roof meningiomas were assessed. Median surgery duration was 3.35 ± 1.42 hours, being significantly longer for OG and AC meningiomas ( <0.05). Complete resection was achieved in 91%. Complications included hyposmia (7.4%), supraorbital hypoesthesia (5.1%), cerebrospinal fluid fistula (5%), orbicularis oculi paresis (2.8%), visual disturbances (2.2%), meningitis (1.7%) and hematoma and wound infection (1.1%). One patient died due to intraoperative carotid injury, other due to pulmonary embolism. Median follow-up was 4.8 years with a tumor recurrence rate of 10.8%. Second surgery was chosen in 12 cases (10 via the previous SOA and two via pterional approach), whereas two patients received radiotherapy and in five patients a wait-and-see strategy was adopted. The eSOA represents an effective option for ASBM resection, enabling high complete resection rates and long-term disease control. Neuroendoscopy is fundamental for improving tumor resection while reducing brain and optic nerve retraction. Potential limitations and prolonged surgical duration may arise from the small craniotomy and reduced maneuverability, especially for large or strongly adherent lesions.
内镜辅助眶上入路(eSOA)是一种切除前颅底脑膜瘤(ASBM)的微创策略。我们开展了最大规模的关于eSOA切除ASBM的单机构回顾性长期随访研究,以进一步深入了解其适应证、手术注意事项、并发症及预后情况。 我们评估了22年间通过eSOA接受ASBM手术的176例患者的数据。 评估了65例鞍结节(TS)、36例前床突(AC)、28例嗅沟(OG)、27例蝶骨平台、11例蝶骨小翼、7例视神经鞘及2例眶外侧壁脑膜瘤。中位手术时间为3.35±1.42小时,OG和AC脑膜瘤的手术时间明显更长(<0.05)。91%的患者实现了全切。并发症包括嗅觉减退(7.4%)、眶上感觉减退(5.1%)、脑脊液漏(5%)、眼轮匝肌麻痹(2.8%)、视觉障碍(2.2%)、脑膜炎(1.7%)以及血肿和伤口感染(1.1%)。1例患者死于术中颈动脉损伤,另1例死于肺栓塞。中位随访时间为4.8年,肿瘤复发率为10.8%。12例患者接受了二次手术(10例通过既往的眶上入路,2例通过翼点入路),2例患者接受了放疗,5例患者采取了观察等待策略。 eSOA是ASBM切除的一种有效选择,能够实现高全切率和长期疾病控制。神经内镜对于提高肿瘤切除率同时减少脑和视神经牵拉至关重要。小骨窗开颅和操作空间减少可能会带来潜在局限性和延长手术时间,尤其是对于大型或粘连紧密的病变。